Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88.
PubMed
Google Scholar
Atlas ID. International Diabetes Federation, 7th edn; 2015.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha FJ, Ohlrogge A, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.
CAS
PubMed
Google Scholar
Ozougwu J, Obimba K, Belonwu C, Unakalamba C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4(4):46–57.
Google Scholar
Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5.
Google Scholar
Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81–90.
Google Scholar
Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M. Complications of diabetes 2016. J Diabetes Res. 2016;2016:6989453.
PubMed
PubMed Central
Google Scholar
Domingueti CP, Dusse LMSA, das Graças Carvalho M, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat. 2016;30(4):738–45.
Google Scholar
Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):e147–67.
PubMed
PubMed Central
Google Scholar
Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48(8):297–309.
CAS
PubMed
Google Scholar
Xiao D, Zeng L, Yao K, Kong X, Wu G, Yin Y. The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications. Amino Acids. 2016;48(9):2067–80.
CAS
PubMed
Google Scholar
da Silva KM, de Bittencourt PIH. Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis. Cell Biochem Funct. 2008;26(4):406–33.
Google Scholar
Molfino A, Logorelli F, Muscaritoli M, Cascino A, Preziosa I, Fanelli FR, et al. Metabolic effects of glutamine on insulin sensitivity. Nutr Ther Metab. 2010;28:7.
CAS
Google Scholar
Samocha-Bonet D, Wong O, Synnott E-L, Piyaratna N, Douglas A, Gribble FM, et al. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. J Nutr. 2011;141(7):1233–8.
CAS
PubMed
Google Scholar
Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A, et al. Oral glutamine increases circulating GLP-1, glucagon and insulin levels in lean, obese and type 2 diabetic subjects. Am J Clin Nutr. 2009a;89(1):106.
CAS
PubMed
Google Scholar
Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713–21.
PubMed
Google Scholar
Badole SL, Jangam GB, Chaudhari SM, Ghule AE, Zanwar AA. L-glutamine supplementation prevents the development of experimental diabetic cardiomyopathy in streptozotocin-nicotinamide induced diabetic rats. PLoS ONE. 2014;9(3):e92697.
PubMed
PubMed Central
Google Scholar
Badole SL, Chaudhari SM, Bagul PP, Mahamuni SP, Khose RD, Joshi AC, et al. Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7–36) amide secretion, biochemical and oxidative stress in streptozotocin-nicotinamide induced diabetic sprague dawley rats. PLoS ONE. 2013;8(8):e72817.
CAS
PubMed
PubMed Central
Google Scholar
Tsai P-H, Liu J-J, Yeh C-L, Chiu W-C, Yeh S-L. Effects of glutamine supplementation on oxidative stress-related gene expression and antioxidant properties in rats with streptozotocin-induced type 2 diabetes. Br J Nutr. 2012;107(8):1112–8.
CAS
PubMed
Google Scholar
Tsai P-H, Liu J-J, Chiu W-C, Pai M-H, Yeh S-L. Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes. Clin Nutr. 2011;30(1):124–9.
CAS
PubMed
Google Scholar
Bataglini C, Rezende DG, Primo MA, Gomes CR, Pedrosa MM, Godoi VA. Glutamine dipeptide and cortisol change the liver glucose metabolism and reduce the severity of insulin-induced hypoglycaemia in untreated T1DM Swiss mice. Arch Physiol Biochem. 2017;123(2):134–44.
CAS
PubMed
Google Scholar
Tsai P-H, Yeh C-L, Liu J-J, Chiu W-C, Yeh S-L. Effects of dietary glutamine on inflammatory mediator gene expressions in rats with streptozotocin-induced diabetes. Nutrition. 2012;28(3):288–93.
CAS
PubMed
Google Scholar
Alba-Loureiro TC, Ribeiro RF, Zorn TMT, Lagranha CJ. Effects of glutamine supplementation on kidney of diabetic rat. Amino Acids. 2010;38(4):1021–30.
CAS
PubMed
Google Scholar
da Rosa CVD, Azevedo SC, Bazotte RB, Peralta RM, Buttow NC, Pedrosa MMD, et al. Supplementation with L-glutamine and L-alanyl-L-glutamine changes biochemical parameters and jejunum morphophysiology in type 1 diabetic Wistar rats. PLoS ONE. 2015;10(12):e0143005.
PubMed
PubMed Central
Google Scholar
Medras ZJ, El-Sayed NM, Zaitone SA, Toraih EA, Sami MM, Moustafa YM. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats. Pharmacol Rep. 2018;70(2):233–42.
CAS
PubMed
Google Scholar
Samocha-Bonet D, Chisholm DJ, Gribble FM, Coster AC, Carpenter KH, Jones GR, et al. Glycemic effects and safety of L-Glutamine supplementation with or without sitagliptin in type 2 diabetes patients-a randomized study. PLoS ONE. 2014;9(11):e113366.
PubMed
PubMed Central
Google Scholar
Samocha-Bonet D, Chisholm DJ, Holst JJ, Greenfield JR. L-glutamine and whole protein restore first-phase insulin response and increase glucagon-like peptide-1 in type 2 diabetes patients. Nutrients. 2015;7(4):2101–8.
CAS
PubMed
PubMed Central
Google Scholar
Mansour A, Mohajeri-Tehrani MR, Qorbani M, Heshmat R, Larijani B, Hosseini S. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes. Nutrition. 2015;31(1):119–26.
CAS
PubMed
Google Scholar
Chang J, Wu T, Greenfield JR, Samocha-Bonet D, Horowitz M, Rayner CK. Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes. Diabetes Care. 2013;36(8):2262–5.
CAS
PubMed
PubMed Central
Google Scholar
Takeuti TD, Terra GA, da Silva AA, Terra JA, da Silva Jr LM, Crema E. Effect of the ingestion of the palm oil and glutamine in serum levels of GLP-1, PYY and glycemia in diabetes mellitus type 2 patients submitted to metabolic surgery. Braz Arch Digest Surg. 2014;27(Suppl 1):51–5.
Google Scholar
Lomivorotov VV, Efremov SM, Shmirev VA, Ponomarev DN, Svyatchenko AV, Deryagin MN, et al. Does glutamine promote benefits for patients with diabetes mellitus scheduled for cardiac surgery? Heart Lung Circ. 2013;22(5):360–5.
PubMed
Google Scholar
Torres-Santiago L, Mauras N, Hossain J, Weltman AL, Darmaun D. Does oral glutamine improve insulin sensitivity in adolescents with type 1 diabetes? Nutrition. 2017;34:1–6.
CAS
PubMed
Google Scholar
Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A, et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr. 2009b;89(1):106–13.
CAS
PubMed
Google Scholar
Meek CL, Lewis HB, Vergese B, Park A, Reimann F, Gribble F. The effect of encapsulated glutamine on gut peptide secretion in human volunteers. Peptides. 2016;77:38–46.
CAS
PubMed
PubMed Central
Google Scholar
Lois K, Kumar S. Obesity and diabetes. Endocrinologia y nutricion: organo de la Sociedad Espanola de Endocrinologia y Nutricion. 2009;56(Suppl 4):38–42.
Google Scholar
Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74(4):761–811.
Article
CAS
PubMed
Google Scholar
de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97–105.
Article
PubMed
CAS
Google Scholar
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409–39.
Article
CAS
PubMed
Google Scholar
Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vanttinen M, Stancakova A, et al. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia. 2008;51(3):502–11.
Article
CAS
PubMed
Google Scholar
Vollmer K, Gardiwal H, Menge BA, Goetze O, Deacon CF, Schmidt WE, et al. Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans. J Clin Endocrinol Metab. 2009;94(4):1379–85.
CAS
PubMed
Google Scholar
Reimann F, Williams L, da Silva XG, Rutter GA, Gribble FM. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia. 2004;47(9):1592–601.
CAS
PubMed
Google Scholar
Andersson LE, Shcherbina L, Al-Majdoub M, Vishnu N, Arroyo CB, Carrara JA, et al. Glutamine-elicited secretion of glucagon-like peptide 1 is governed by an activated glutamate dehydrogenase. Diabetes. 2018;67(3):372–84.
CAS
PubMed
Google Scholar
Prada P, Hirabara S, De Souza C, Schenka A, Zecchin H, Vassallo J, et al. RETRACTED ARTICLE: l-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity. Diabetologia. 2007;50(9):1949–59.
CAS
PubMed
Google Scholar
Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, et al. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol. 2011;54(6):1214–23.
CAS
PubMed
Google Scholar
Armstrong MJ, Hull D, Guo K, Barton D, Hazlehurst JM, Gathercole LL, et al. Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. J Hepatol. 2016;64(2):399–408.
CAS
PubMed
PubMed Central
Google Scholar
Opara EC, Petro A, Tevrizian A, Feinglos MN, Surwit RS. L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. J Nutr. 1996;126(1):273–9.
CAS
PubMed
Google Scholar
Joo E, Muraoka A, Hamasaki A, Harada N, Yamane S, Kondo Y, et al. Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion. J Diabetes Investig. 2015;6(3):302–8.
CAS
PubMed
Google Scholar
Xu F, Lin B, Zheng X, Chen Z, Cao H, Xu H, et al. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1. Diabetologia. 2016;59(5):1059–69.
CAS
PubMed
Google Scholar
Romanelli MMC, Vianello E, Malavazos AE, Tacchini L, Schmitz G, Iacobellis G, et al. GLP-1 receptor is associatedwith genes involved in fatty acids oxidation and white-to-brown fat differentiation in epicardial adipose tissue (EAT). FASEB J. 2019;33(1_supplement):662.21.
Google Scholar
De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver. 2012;6(1):10.
PubMed
PubMed Central
Google Scholar
Shah M, Vella A. Effects of GLP-1 on appetite and weight. Rev Endocr Metab Disorders. 2014;15(3):181–7.
CAS
Google Scholar
Marques C, Mauriz JL, Simonetto D, Marroni CA, Tuñon MJ, González-Gallego J, et al. Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy. Ann Hepatol. 2016;10(4):531–9.
Google Scholar
Aboud OA, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ, et al. Glutamine addiction in kidney cancer suppresses oxidative stress and can be exploited for real-time imaging. Can Res. 2017;77(23):6746–58.
Google Scholar
Mahdavifard S, Nakhjavani M. Effect of glutamine on oxidative stress, inflammatory, and glycation markers, and the activity of glyoxalase system in diabetic rats with atherosclerosis. J Mazandaran Univ Med Sci. 2019;28(170):33–42.
Google Scholar